{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:01:21Z","timestamp":1775822481505,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03790-y","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:34:09Z","timestamp":1772631249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological trends and risk attribution of early-onset liver cancer: insights from the Global Burden of Disease study 2021"],"prefix":"10.1186","volume":"31","author":[{"given":"Xiaofei","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"3","key":"3790_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3790_CR2","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.32604\/or.2024.047524","volume":"32","author":"J Yi","year":"2024","unstructured":"Yi J, Li B, Yin X, Liu L, Song C, Zhao Y, et al. CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression. Oncol Res. 2024;32(6):1129\u201339.","journal-title":"Oncol Res"},{"key":"3790_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1382520","volume":"15","author":"Z Yuan","year":"2024","unstructured":"Yuan Z, Li B, Liao W, Kang D, Deng X, Tang H, et al. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer. Front Immunol. 2024;15:1382520.","journal-title":"Front Immunol"},{"issue":"4","key":"3790_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11427-023-2445-1","volume":"67","author":"Y Teng","year":"2024","unstructured":"Teng Y, Xia C, Li H, Cao M, Yang F, Yan X, et al. Cancer statistics for young adults aged 20 to 49 years in China from 2000 to 2017: a population-based registry study. Sci China Life Sci. 2024;67(4):711\u20139.","journal-title":"Sci China Life Sci"},{"issue":"5","key":"3790_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1515\/jtim-2024-0023","volume":"12","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li J, Ma M, Fu W, Ma L, Sui Y, et al. Prognostic prediction of m6A and ferroptosis-associated lncRNAs in liver hepatocellular carcinoma. J Transl Intern Med. 2024;12(5):526\u20139.","journal-title":"J Transl Intern Med"},{"issue":"4","key":"3790_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/HEP.0000000000000872","volume":"80","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul P, Aboona MB, Sukphutanan B, Kongarin S, Duangsonk K, Ng CH, et al. Incidence of liver cancer in young adults according to the Global Burden of Disease database 2019. Hepatology. 2024;80(4):828\u201343.","journal-title":"Hepatology"},{"issue":"12","key":"3790_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114912","volume":"9","author":"A Marchio","year":"2014","unstructured":"Marchio A, Bertani S, Rojas Rojas T, Doimi F, Terris B, Deharo E, et al. A peculiar mutation spectrum emerging from young Peruvian patients with hepatocellular carcinoma. PLoS One. 2014;9(12):e114912.","journal-title":"PLoS One"},{"issue":"7","key":"3790_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28497","volume":"10","author":"H Zhu","year":"2024","unstructured":"Zhu H, Zhao S, Zhao T, Chen L, Li S, Ji K, et al. Comparison of metastasis and prognosis between early-onset and late-onset hepatocellular carcinoma: a population-based study. Heliyon. 2024;10(7):e28497.","journal-title":"Heliyon"},{"issue":"3","key":"3790_CR9","first-page":"225","volume":"12","author":"B Wang","year":"2024","unstructured":"Wang B, Hao X, Yan J, Li X, Zhao M, Han T. A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma. J Transl Int Med. 2024;12(3):225\u201343.","journal-title":"J Transl Int Med"},{"key":"3790_CR10","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04167","volume":"13","author":"C Guo","year":"2023","unstructured":"Guo C, Liu Z, Lin C, Fan H, Zhang X, Wang H, et al. Global epidemiology of early-onset liver cancer attributable to specific aetiologies and risk factors from 2010 to 2019. J Glob Health. 2023;13:04167.","journal-title":"J Glob Health"},{"issue":"10481","key":"3790_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(25)00397-6","volume":"405","author":"GBD 2021 Adolescent BMI Collaborators","year":"2025","unstructured":"GBD 2021 Adolescent BMI Collaborators. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405(10481):785\u2013812.","journal-title":"Lancet"},{"issue":"10440","key":"3790_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10440","key":"3790_CR13","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100\u201332.","journal-title":"Lancet"},{"issue":"1","key":"3790_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023-000049","volume":"2","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2(1):e000049.","journal-title":"BMJ Oncol"},{"issue":"8","key":"3790_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamapediatrics.2023.2029","volume":"177","author":"K Zhang","year":"2023","unstructured":"Zhang K, Kan C, Han F, Zhang J, Ding C, Guo Z, et al. Global, regional, and national epidemiology of diabetes in children from 1990 to 2019. JAMA Pediatr. 2023;177(8):837\u201346.","journal-title":"JAMA Pediatr"},{"issue":"7","key":"3790_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S2468-1253(22)00044-9","volume":"7","author":"GBD 2019 Colorectal Cancer Collaborators","year":"2022","unstructured":"GBD 2019 Colorectal Cancer Collaborators. Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(7):627\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10440","key":"3790_CR17","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"4","key":"3790_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674\u201383.","journal-title":"J Hepatol"},{"issue":"1","key":"3790_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00649-y","volume":"12","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Huang G, Cai X, Liu Y, Qian B, Li D. Global, regional, and national burden of acute myeloid leukemia, 1990-2021: a systematic analysis for the global burden of disease study 2021. Biomark Res. 2024;12(1):101.","journal-title":"Biomark Res"},{"issue":"2","key":"3790_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jcmgh.2022.11.001","volume":"15","author":"SH Wang","year":"2023","unstructured":"Wang SH, Yeh SH, Chen PJ. Androgen enhances aflatoxin-induced genotoxicity and inflammation to liver cancer in male hepatitis B patients. Cell Mol Gastroenterol Hepatol. 2023;15(2):507\u20138.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"15","key":"3790_CR21","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1158\/0008-5472.CAN-23-3966","volume":"84","author":"W He","year":"2024","unstructured":"He W, Wang M, Zhang X, Wang Y, Zhao D, Li W, et al. Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development. Cancer Res. 2024;84(15):2417\u201331.","journal-title":"Cancer Res"},{"issue":"3","key":"3790_CR22","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1530\/EJE-16-1063","volume":"177","author":"D Macut","year":"2017","unstructured":"Macut D, Bo\u017ei\u0107-Anti\u0107 I, Bjeki\u0107-Macut J, Tziomalos K. Management of endocrine disease: polycystic ovary syndrome and nonalcoholic fatty liver disease. Eur J Endocrinol. 2017;177(3):R145-r158.","journal-title":"Eur J Endocrinol"},{"issue":"10347","key":"3790_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(22)00847-9","volume":"400","author":"GBD 2020 Alcohol Collaborators","year":"2022","unstructured":"GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022;400(10347):185\u2013235.","journal-title":"Lancet"},{"issue":"8","key":"3790_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1473-3099(15)00158-9","volume":"15","author":"CL Thio","year":"2015","unstructured":"Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis. 2015;15(8):981\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3790_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3350\/cmh.2017.0104","volume":"23","author":"EJ Cho","year":"2017","unstructured":"Cho EJ, Kim SE, Suk KT, An J, Jeong SW, Chung WJ, et al. Current status and strategies for hepatitis B control in Korea. Clin Mol Hepatol. 2017;23(3):205\u201311.","journal-title":"Clin Mol Hepatol"},{"key":"3790_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1381173","volume":"14","author":"O Batsaikhan","year":"2024","unstructured":"Batsaikhan O, Chimed-Ochir O, Kubo T, Jigjidsuren C, Delgermaa V, Purevdagva A, et al. The burden of liver cancer in Mongolia from 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Front Oncol. 2024;14:1381173.","journal-title":"Front Oncol"},{"issue":"2","key":"3790_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ijc.30463","volume":"140","author":"T Chimed","year":"2017","unstructured":"Chimed T, Sandagdorj T, Znaor A, Laversanne M, Tseveen B, Genden P, et al. Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008\u201312. Int J Cancer. 2017;140(2):302\u20139.","journal-title":"Int J Cancer"},{"key":"3790_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1101\/cshperspect.a036947","volume":"10","author":"AL Cox","year":"2020","unstructured":"Cox AL. Challenges and promise of a hepatitis C virus vaccine. Cold Spring Harb Perspect Med. 2020;10:2.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"45","key":"3790_CR29","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.3748\/wjg.v12.i45.7239","volume":"12","author":"F Lodato","year":"2006","unstructured":"Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol. 2006;12(45):7239\u201349.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3790_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S2468-1253(23)00071-7","volume":"8","author":"HN Njuguna","year":"2023","unstructured":"Njuguna HN, Hiebert L, Gupta N, Ward JW. Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy development. Lancet Gastroenterol Hepatol. 2023;8(6):502\u20133.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"3790_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrgastro.2016.138","volume":"13","author":"JP Allain","year":"2016","unstructured":"Allain JP, Opare-Sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol. 2016;13(11):643\u201353.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"3790_CR32","first-page":"88","volume":"69","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69(2):88\u2013112.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3790_CR33","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jama.2019.13771","volume":"322","author":"Z Shan","year":"2019","unstructured":"Shan Z, Rehm CD, Rogers G, Ruan M, Wang DD, Hu FB, et al. Trends in dietary carbohydrate, protein, and fat intake and diet quality among US adults, 1999-2016. JAMA. 2019;322(12):1178\u201387.","journal-title":"JAMA"},{"issue":"1","key":"3790_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3350\/cmh.2020.0176","volume":"27","author":"W Sohn","year":"2021","unstructured":"Sohn W, Lee HW, Lee S, Lim JH, Lee MW, Park CH, et al. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis. Clin Mol Hepatol. 2021;27(1):157\u201374.","journal-title":"Clin Mol Hepatol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03790-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:17:34Z","timestamp":1775819854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03790-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3790"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03790-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"535"}}